We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Recurrent meningioma: When to intervene

Abstract & Overview

Meningioma occurs most frequently as a benign tumor central nervous system that is common in old females. Radiation exposure and deletion of the NF2 gene are known risk factors. However, there is no consensus about the role of sex hormones. Meningiomas are usually benign tumors, but 6% can be anaplastic or atypical. Most asymptomatic patients do not require treatment, but complete surgical resection is recommended for symptomatic patients. If a tumor returns after being resected previously, it is recommended to be resected, followed by radiotherapy in some cases. Meningiomas (benign, atypical, and malignant) recurring after standard treatment fails could be treated with hormone therapy, chemotherapy, target therapy, and calcium channel blockers.

Cite this record

Mohammad-Reza Hosseini-Siyanaki, Zahra Hasanpour Segherlou, Sophie N. Liu, Mohammed Atef Azab, Majid Khan, Brandon P. Lucke-Wold (2023). Recurrent meningioma: When to intervene. BOHR International Journal of Neurology and Neuroscience, 1(2), 50–58. https://doi.org/10.54646/bijnn.2023.08

Copy in another style

Hosseini-Siyanaki, M., Segherlou, Z. H., Liu, S. N., Azab, M. A., Khan, M., & Lucke-Wold, B. P. (2023). Recurrent meningioma: When to intervene. BOHR International Journal of Neurology and Neuroscience, 1(2), 50–58. https://doi.org/10.54646/bijnn.2023.08
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.